Market News AIOpen the app

TXG stock news · 10x Genomics

Stories about 10x Genomics (TXG) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for TXG

Follow 10x Genomics (TXG) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TXG
Free on the App Store and Google Play, or on the web.
  1. Nov 5, 2026, 7:53 PM ET · Market

    10x Genomics made $150.7 million last quarter, which was more than expected, and raised its yearly revenue forecast to $625 million to $635 million.

    Good for TXG

    10x Genomics sales were $150.7 million, above $148.0 million expected, and its 2026 forecast rose to $625–$635 million from $610–$630 million. This favors the company.